January 8, 2026
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today, Florida is back in court with the same playbook and higher friction, with ballot wording, signature verification, and a 60% threshold all doing the work of politics. We also track Ohio’s first full-year adult-use numbers, the quiet move from cannabis banking to cannabis credit, and the federal hemp fight that is forcing retail and wholesalers to plan around a cliff before it arrives.
Policy, Decoded is produced by THC Group. We advise operators, brands, trade groups, investors, and policymakers on cannabis and hemp regulation, legislative strategy, compliance posture, and crisis-response when the rules or market need updating. Also listen to The Hybrid podcast hosted by former regulators Shawn Collins and Erik Gundersen. A new episode will drop next week!
⚖️ Florida ballot fight
🏦 Credit replaces cash
🌾 Hemp rules clock
Rules move. Markets react. We decode.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: Florida Attorney General James Uthmeier asked the Florida Supreme Court to keep the 2026 adult-use initiative off the ballot, arguing the summary misleads voters on public consumption and leaning hard on federal conflict arguments. The Court cleared a near-twin measure for the 2024 ballot, and most of the same justices are still there, so the legal posture feels familiar. The campaign is also under the February 1st signature verification gun, and Florida’s newer initiative rules have made verification a fight all by itself. Big batches have been tossed, and the campaign has responded the way every major Florida campaign does now, with lawsuits. Oral argument is set for February 5th, which means Florida will be litigating the rules of the game while the clock is still running.
💡 Why It Matters: Florida’s political class does not want to legalize adult use, and it shows in how the state plays defense. You need 60% to pass a constitutional amendment, which turns a clear majority into a loss and encourages politicians to govern against the median voter. When the state can kill a measure on ballot wording, signatures, or timing, it never has to debate the merits in good faith. In 2024, the opposition even took the fight into the airwaves with taxpayer-backed messaging, and the public-consumption and smell theme became the emotional hook. This round, the Attorney General is back at the same pressure point, trying to make the question feel like a promise Florida cannot keep about what people will see and smell in everyday life. Florida is the national template for blocking voter-led policy through process, money, and a supermajority rule that rewards obstruction.
🧠 THC Group Take: Florida has the demand, the tourism, the infrastructure, and the capital. It has everything you would want for a big, boring, well-regulated market that throws off jobs and tax revenue and gives law enforcement fewer low-level headaches. Then Tallahassee shows up and decides it would rather keep the state stuck than admit voters might be right. The 60% rule is the main tool, and the rest is just technique: make the signature process painful, fight the wording, run the clock, and let the courts take the heat. The public-consumption and odor theme is the political lever because it turns a regulatory question into a daily quality-of-life complaint, and that is easier to sell than a sober conversation about licensing and enforcement. The part that still stands out is that even Trump endorsed the last measure, and it still fell short, which tells you how disciplined the opposition machine is and how hard the last few points are. If this clears the ballot, the winning path is a campaign that talks like a neighbor and governs like an adult: clear boundaries, credible enforcement, and a market structure that looks normal enough for suburban voters to stop worrying and just vote yes.
Fast-moving headlines, flagged for what matters.
Florida Attorney General James Uthmeier asked the Florida Supreme Court to invalidate the Smart and Safe Florida adult-use initiative, arguing the ballot summary misleads voters, including on public use and smell. The maneuver fits Florida’s preferred lane: win in court before voters get a say, then force proponents to restart the expensive signature grind. A second gate remains the signature fight, with large batches under scrutiny ahead of the February 1st deadline. Even if the measure survives, Florida’s 60% supermajority requirement turns a simple majority into a loss, and 2024 proved it. The consequence is planning risk that stays elevated until the court ruling and signature count are locked. (MJBizDaily)
A stopgap federal funding bill added hemp language that would cap total THC at 0.4 milligrams per container for final hemp-derived cannabinoid products. The limits do not take effect until November 12th, which gives the category a year to push Congress toward an age-gated, alcohol-style compliance model for low-dose drinks. The supply chain will not wait for that date, and wholesalers will not warehouse products that could be stranded by a federal cliff. This is the moment where disciplined low-dose beverages either get carved out from synthetics and reckless formats or get swept into the same bucket. The consequence is accelerated lobbying and earlier commercial pullback as retailers price in uncertainty. (NACS Magazine)
Ohio’s adult-use market posted $836 million in sales in 2025, its first full year of recreational sales after launch in August 2024. The state now reports more than $1.09 billion in total adult-use sales as of early January, and prices have continued to ease as supply and competition expand. The local map stays uneven, with more than 130 municipalities and townships maintaining moratoriums even as 190 dual-use dispensaries operate. New statutory changes taking effect in March tighten product rules and target intoxicating hemp, and a referendum effort is already forming to block them. The consequence is a large market growing fast while the rules and local access picture remain unsettled. (Ohio Capital Journal)
Cannabis banking is shifting from deposit services to lending, and the underwriting questions are now landing in credit committees. Green Check says more than $1.3 billion in compliant cannabis transactions flow through its platform each month, and it argues that visibility has turned lending into the next competitive frontier. The piece says roughly forty percent of financial institutions already serving cannabis offer some form of lending, including real estate, equipment, and working capital. Operators with clean tax posture, reconciled books, and reliable point-of-sale data will see better terms and more refinance and acquisition options. The consequence is a widening gap between financeable operators and businesses that still look like cash-only risk. (mg Magazine)
Challengers say paid signature gatherers for a Massachusetts initiative to roll back adult-use sales used deceptive tactics and misrepresented what voters were signing. Industry advocates are urging anyone who feels misled to contact local election officials and seek to withdraw signatures from certification. The repeal campaign denies wrongdoing and casts the allegations as an industry counterattack. The sponsors behind this question are also tied to similar repeal efforts in other states, so the industry should treat this as a scalable playbook, not a one-off local fight. The consequence is a campaign that may move procedurally while carrying a legitimacy cloud and a warning for other states to watch for the same signature-collection shenanigans. (State House News Service)
The National Police Chiefs’ Council approved its first official guidance for police encounters involving prescribed medical cannabis, years after UK medical legality. The guidance tells officers to treat possession as lawful unless there are clear grounds to believe otherwise, and it lays out practical verification steps focused on packaging and dispensing labels. It also acknowledges a basic operational reality: patients are not legally required to carry extra documentation, which is where many street encounters have gone sideways. The guidance pushes forces toward consistency instead of one-off discretion that turns lawful patients into suspects. The consequence is fewer needless seizures and stops if training catches up with the policy. (Cannabis Health News)
A Pediatrics commentary warns that unflavored THC drink mixers create a distinct accidental exposure risk because they can be added to any beverage without obvious taste cues. The authors argue product design matters as much as dose, since these formats travel easily and make it harder to detect THC presence in a home. Expect this to strengthen arguments for tighter packaging, clearer dosing controls, and narrower retail placement for mix-in products that function like concentrates. This line of critique is not aimed at disciplined, labeled low-dose canned beverages. The consequence is pressure on policymakers to draw sharper product-category lines instead of treating all drinks as the same. (American Academy of Pediatrics)
A Vicente overview traces Tennessee’s hemp-derived cannabinoid rules through shifting agencies and court fights before landing with the Tennessee Alcoholic Beverage Commission. The operational risk is timing, since obligations can turn on license dates and transition windows that are easy to misread. The new framework looks like alcohol, with three-tier licensing concepts, tighter testing and labeling expectations, and real inspection and enforcement authority. It also eliminates direct-to-consumer sales and delivery, which forces brands back into wholesale relationships and compliant retail placement. The consequence is consolidation as enforcement grows teeth and legacy operators either relicense cleanly or exit. (Vicente LLP)
New Hampshire’s House advanced legislation putting adult-use legalization back at the center of the 2026 session. The bill would legalize adult possession, allow limited home cultivation, and tax sales through the Meals and Rooms rate of 8.5%. It also contemplates municipal opt-in votes and a new Cannabis Commission, which pulls governance and fiscal assumptions into the spotlight early. The bill now heads into the House Finance process where amendments can either tighten credibility or bog the framework down. The consequence is another year where New Hampshire stays a regional outlier unless Senate dynamics change. (Seacoastonline)
Kentucky’s first medical dispensary says it plans to reopen in mid-January once new inventory arrives, and patients will watch closely for consistency after the initial rush. The first-week sellout proved demand, and the reopening will test whether licensed cultivation can deliver steady cadence instead of bursts. Kentucky’s in-state production requirement keeps the supply chain local, and early-stage ramp makes gaps obvious quickly. The market will also show whether product form and selection can broaden under rules that steer patients away from smoking. The consequence is a credibility moment for a new program that has little room for repeated dry spells. (WDRB)
A Michigan Daily columnist is urging Ann Arbor to widen school buffers after City Council reduced the minimum distance between dispensaries and schools from 1,000 feet to 100 feet in November. The column argues proximity and advertising normalize youth use and points to studies linking nearby dispensaries to higher reported access and consumption. The policy tension in Ann Arbor is practical: how the city balances compliant commerce with school-adjacent exposure while also debating whether to loosen caps on the number of retailers. The ordinance change also carries a visible local consequence, since it helps existing dispensaries stay open near preschools. The consequence is renewed pressure on zoning and licensing as youth protection becomes a local political organizing frame. (The Michigan Daily)
Germany’s medical supply chain continues to scale, with official import data showing about 62.7 short tons in Q3 2025, roughly 125,000 pounds. Imports across the first nine months of 2025 totaled about 156.5 short tons, roughly 313,000 pounds, keeping momentum concentrated in pharmacy channels. On the adult-use side, cultivation associations are growing while pilot retail trials remain stalled, leaving the consumer access model incomplete. That split keeps growth rooted in medical distribution while policymakers debate how to make the broader framework real. The consequence is Germany anchoring European medical volume and pricing while adult-use implementation takes longer than advocates expected. (Cannabis Now)
Thailand is weighing rules that would confine cannabis sales primarily to licensed medical facilities, with limited sales also allowed through pharmacies and traditional medicine channels. The framework raises operational thresholds, including expectations for trained personnel and tighter controls, as officials move to rein in the post-2022 dispensary boom. Reporting suggests a major contraction already, with thousands of shops closing as renewals slowed ahead of stricter compliance. Existing licenses would generally run to expiry, while renewals and new applications would face upgraded criteria once the rules take effect. The consequence is consolidation and whiplash risk for businesses built around a tourist-facing retail surge. (Ganjapreneur)
A craft beer outlet is treating cannabis beverages as a Dry January substitute and discussing them as part of mainstream beverage choice. That framing matters because it pulls THC drinks into the same conversation as beer, distribution, and brand loyalty, not novelty retail. The category’s policy problem remains channel chaos, since legality and access still vary sharply by state and could tighten federally. Serious brands will keep leaning into disciplined dosing, age-gating, and packaging standards that alcohol compliance teams recognize. The consequence is a larger audience watching the category and faster backlash when products or channels look sloppy. (American Craft Beer)
Guam lawmakers are backing a bill to extend a temporary exemption from cannabis laboratory testing because the island still lacks an accredited testing facility. Pending legislation would extend the waiver for up to five more years or until a compliant lab becomes operational, and regulators raised no objections during a public hearing. Supporters framed the move as a bridge that avoids penalizing licensed businesses for delays outside their control. Operators also used the hearing to describe broader bureaucratic friction slowing lab licensing, zoning, and financing. The consequence is a longer runway for legal sales paired with sharper expectations that Guam proves it can stand up testing capacity. (Guam Daily Post)
Rep. Dina Titus urged President Trump’s incoming drug czar to support full legalization and descheduling and to adopt a science-first posture. The request reads as messaging more than leverage, since Titus has limited pull over an administration that will set its own drug policy priorities. Her most concrete angle is the ONDCP gag rule that bars the director from advocating legalization of Schedule I drugs, which gives reformers a ready-made oversight question. If that restriction ever changes, ONDCP becomes another venue where legalization arguments can be forced into the open. The consequence is more public positioning on Capitol Hill while the real rescheduling drama stays with administrative process and litigation risk. (Marijuana Moment)
From the hearing room to the comment section — we’re watching it all.
📊 A new New Year’s resolution poll found Americans are more likely to say they want to cut back on alcohol and tobacco than on marijuana in 2026. Cannabis came in last among the substance options, with 8% saying they want to reduce or stop use, a small but telling snapshot of how normalized consumption has become for a growing share of adults. That cultural drift matters because it feeds the demand story for low-dose beverages and intensifies the fight over who regulates them and where they can be sold. (Marijuana Moment)
🌈 The Bay Area Reporter editorial board credited President Trump’s December 18th executive order on Schedule III as a rare constructive move and urged his administration to finish the Biden-started rescheduling effort. The piece ties the moment to San Francisco’s medical cannabis history and Denis Peron’s legacy, framing federal delay as the main barrier to research and patient access. Cross-tribe validation like this gives rescheduling political oxygen and raises the cost of a quiet reversal inside the party. (Bay Area Reporter)
🍹 Vice is pitching THC seltzers as a Dry January substitute, framed as a normal consumer choice with lighter next-day consequences than alcohol. The article’s recommended brands include a few familiar names from our own orbit, which says a lot about how quickly this category is professionalizing. That mainstream lifestyle packaging raises the stakes for lawmakers trying to separate compliant low-dose, age-gated drinks from synthetics and sloppy channels. When consumers start treating these as routine, federal rewrites and state crackdowns land as a disruption, not a course correction. (Vice)
👔 Common Citizen hired Robert Beasley as CEO, a signal that Michigan’s price compression is pushing larger operators toward disciplined turnaround leadership. Expect a sharper focus on cost control, store-level execution, and balance sheet triage over growth theater. (Crain’s Detroit Business)